Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode

N. M. Vyalova, I. V. Pozhidaev, D. Z. Osmanova, G. G. Simutkin, S. A. Ivanova, N. A. Bokhan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective. To study the association between polymorphisms of PIP5K2A and HTR2C genes and response to antidepressant therapy in patients with a current depressive episode. Material and methods. The study included 222 patients (168 women and 54 men) with a current depressive episode. The assessment of the severity of the current depressive episode and the efficacy of treatment was performed using the Hamilton depression scale (HDRS-17) and the Clinical global impression scale (CGI-S, CGI-I). The association of treatment efficacy with PIP5K2A polymorphisms rs10430590, rs10828317 and HTR2C polymorphisms rs6318, rs569959, rs3813929, rs12858300 was studied. Results and conclusion. Polymorphisms rs10828317 and rs10430590 in the PIP5K2A gene were associated with the CGI-S total score at day 28 of therapy. Polymorphism rs6318 in the HTR2C gene was associated with response to antidepressant therapy followed by clinical improvement of patients with current depressive episode on the 28th day of antidepressant therapy.

Original languageEnglish
Pages (from-to)58-61
Number of pages4
JournalZhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova
Volume117
Issue number5
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

Fingerprint

Antidepressive Agents
Genes
Therapeutics

Keywords

  • Depressive episode
  • Gene polymorphism
  • HTR2C
  • PIP5K2A
  • Treatment efficacy

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode. / Vyalova, N. M.; Pozhidaev, I. V.; Osmanova, D. Z.; Simutkin, G. G.; Ivanova, S. A.; Bokhan, N. A.

In: Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, Vol. 117, No. 5, 01.01.2017, p. 58-61.

Research output: Contribution to journalArticle

@article{8d4a5f0a049a4d17bee8dc38e45c060a,
title = "Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode",
abstract = "Objective. To study the association between polymorphisms of PIP5K2A and HTR2C genes and response to antidepressant therapy in patients with a current depressive episode. Material and methods. The study included 222 patients (168 women and 54 men) with a current depressive episode. The assessment of the severity of the current depressive episode and the efficacy of treatment was performed using the Hamilton depression scale (HDRS-17) and the Clinical global impression scale (CGI-S, CGI-I). The association of treatment efficacy with PIP5K2A polymorphisms rs10430590, rs10828317 and HTR2C polymorphisms rs6318, rs569959, rs3813929, rs12858300 was studied. Results and conclusion. Polymorphisms rs10828317 and rs10430590 in the PIP5K2A gene were associated with the CGI-S total score at day 28 of therapy. Polymorphism rs6318 in the HTR2C gene was associated with response to antidepressant therapy followed by clinical improvement of patients with current depressive episode on the 28th day of antidepressant therapy.",
keywords = "Depressive episode, Gene polymorphism, HTR2C, PIP5K2A, Treatment efficacy",
author = "Vyalova, {N. M.} and Pozhidaev, {I. V.} and Osmanova, {D. Z.} and Simutkin, {G. G.} and Ivanova, {S. A.} and Bokhan, {N. A.}",
year = "2017",
month = "1",
day = "1",
doi = "10.17116/jnevro20171175158-61",
language = "English",
volume = "117",
pages = "58--61",
journal = "Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova",
issn = "0044-4588",
publisher = "Media Sfera",
number = "5",

}

TY - JOUR

T1 - Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode

AU - Vyalova, N. M.

AU - Pozhidaev, I. V.

AU - Osmanova, D. Z.

AU - Simutkin, G. G.

AU - Ivanova, S. A.

AU - Bokhan, N. A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective. To study the association between polymorphisms of PIP5K2A and HTR2C genes and response to antidepressant therapy in patients with a current depressive episode. Material and methods. The study included 222 patients (168 women and 54 men) with a current depressive episode. The assessment of the severity of the current depressive episode and the efficacy of treatment was performed using the Hamilton depression scale (HDRS-17) and the Clinical global impression scale (CGI-S, CGI-I). The association of treatment efficacy with PIP5K2A polymorphisms rs10430590, rs10828317 and HTR2C polymorphisms rs6318, rs569959, rs3813929, rs12858300 was studied. Results and conclusion. Polymorphisms rs10828317 and rs10430590 in the PIP5K2A gene were associated with the CGI-S total score at day 28 of therapy. Polymorphism rs6318 in the HTR2C gene was associated with response to antidepressant therapy followed by clinical improvement of patients with current depressive episode on the 28th day of antidepressant therapy.

AB - Objective. To study the association between polymorphisms of PIP5K2A and HTR2C genes and response to antidepressant therapy in patients with a current depressive episode. Material and methods. The study included 222 patients (168 women and 54 men) with a current depressive episode. The assessment of the severity of the current depressive episode and the efficacy of treatment was performed using the Hamilton depression scale (HDRS-17) and the Clinical global impression scale (CGI-S, CGI-I). The association of treatment efficacy with PIP5K2A polymorphisms rs10430590, rs10828317 and HTR2C polymorphisms rs6318, rs569959, rs3813929, rs12858300 was studied. Results and conclusion. Polymorphisms rs10828317 and rs10430590 in the PIP5K2A gene were associated with the CGI-S total score at day 28 of therapy. Polymorphism rs6318 in the HTR2C gene was associated with response to antidepressant therapy followed by clinical improvement of patients with current depressive episode on the 28th day of antidepressant therapy.

KW - Depressive episode

KW - Gene polymorphism

KW - HTR2C

KW - PIP5K2A

KW - Treatment efficacy

UR - http://www.scopus.com/inward/record.url?scp=85021966953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021966953&partnerID=8YFLogxK

U2 - 10.17116/jnevro20171175158-61

DO - 10.17116/jnevro20171175158-61

M3 - Article

VL - 117

SP - 58

EP - 61

JO - Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

JF - Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

SN - 0044-4588

IS - 5

ER -